FAP-targeted [177Lu]Lu-FAP-2286 radioligand therapy synergizes with the STING agonist diABZI to enhance antitumor immunity in lung cancer

Nuclear Medicine and Biology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles